PCSK9 and obesity due to melanocortin 4 receptor deficiency: Low PCSK9 plasma levels were associated with a particular metabolic phenotype (low HDL cholesterol, the metabolic syndrome, obesity, insulin resistance and diabetes) [26] and a higher computed tomography angiography score which was computed by combining the extent, severity, composition, and location of atherosclerotic plaques [27].